Atsena Therapeutics

Developer of ocular gene therapies designed to reverse or prevent blindness. The company's programs include treatments for leading forms of Leber congenital amaurosis and Usher syndrome and have a pip...

Healthcare
Durham, NC, United States
Founded 2019
32 employees
Website
Valuation
$340M
Market implied
Share Price
N/A
Total Raised
$237.7M
Last Round
N/A

Get the full picture

Create a free account to unlock Atsena Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required